相关实验视频

Updated: Jun 2, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

强大的基因组编辑活动和增强微型CRISPR-Cas12f1的应用

Soo-Ji Park^1,2, Sungjin Ju^1,2, Won Jun Jung^1,2

¹Department of Physiology, Korea University College of Medicine, Seoul, Republic of Korea.

Nature communications

|January 14, 2025

概括

研究人员开发了增强的Cas12f1 (eCas12f1),一个紧的基因编辑器. 这种新工具提高了CRISPR/Cas基因编辑效率,显示了基因治疗应用的前景.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
基因编辑技术的技术

背景情况:

克里斯普尔/卡斯系统对于基因编辑至关重要,但高效的输入细胞受到系统大小的限制.
像Un1Cas12f1这样的紧CRISPR-Cas变体提供了交付优势,但通常显示编辑效率低.
提高CRISPR编辑器的效率对于推进基因疗法至关重要.

研究的目的:

开发一个高效和紧的CRISPR-Cas基因编辑器.
克服现有的小型CRISPR系统的局限性,例如Un1Cas12f1.1.
验证增强编辑器在基因治疗环境中的实用性.

主要方法:

Un1Cas12f1系统的工程设计,以创建增强的Cas12f1 (eCas12f1).
对不同目标站点的eCas12f1编辑效率与SpCas9和AsCpf1进行比较分析.
评估eCas12f1在癌细胞中诱导细胞亡的能力.
证明eCas12f1与基因编辑和基因表达调节的兼容性.

主要成果:

开发的eCas12f1表现出与SpCas9和AsCpf1.1相当的基因编辑活动.
即使在之前的Un1Cas12f1变种无效的网站上,eCas12f1也表现出高的编辑效率.
在癌细胞中,eCas12f1成功诱导了细胞亡.
eCas12f1与基因编辑和基因表达调制兼容.

结论:

增强的Cas12f1 (eCas12f1) 代表了紧的基因编辑工具的重大进步.
eCas12f1克服了较小的CRISPR系统的效率限制,扩大了基因治疗的潜力.
在癌症治疗和基因调节中展示的应用突显了eCas12f1的多功能性.

更多相关视频

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art

CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art

Published on: May 28, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...